EUVIMEDEUVIMED entdecken
Crossref

Dynamic Risk Stratification for Predicting Long-term Outcomes in Pediatric Differentiated Thyroid Cancers

Althaf K Majeed, Swayamjeet Satapathy iD, Sanjana Ballal, Chandrasekhar Bal iD

The Journal of Clinical Endocrinology & Metabolism · 2023

DOI: 10.1210/clinem/dgac731 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Althaf K Majeed und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi 110029, India. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The American Thyroid Association (ATA) guidelines recommend Dynamic Risk Stratification (DRS) for predicting long-term outcomes and personalizing management in adult differentiated thyroid cancers (DTCs). However, its applicability in pediatric DTCs needs to be validated.

Objective

We have attempted a validation study concerning the use of DRS in pediatric DTCs.

Methods

Data of children (age ≤18 years) with DTCs and follow-up of ≥5 years were extracted. All patients were classified according to DRS (excellent biochemical or structural incomplete responses). Univariate and multivariate analyses were done to identify factor(s) affecting disease-free survival (DFS).

Results

We included 176 pediatric patients with DTC (median age at diagnosis 15 years). All patients underwent thyroidectomy and received radioiodine as part of initial management. On the basis of clinical, biochemical, and imaging findings acquired during the first 2 years of follow-up, the DRS system divided patients into 3 response categories: excellent response in 82/176 (46.6%), biochemical incomplete response in 56/176 (31.8%), and structural incomplete response in 38/176 (21.6%) patients. The median follow-up was 10.6 years (interquartile range 7.7-15.5). Ten-year overall survival and DFS rates were 100% and 88.7%, respectively. In univariate analysis, DFS was significantly affected by extrathyroidal extension (P = .002), lymph node metastasis (P = .018), ATA initial risk stratification (P = .033), and DRS (P = .004). However, in multivariate analysis, DRS alone showed a significant association with DFS (P = .016).

Conclusion

Like adults, DRS correctly predicts long-term outcomes in pediatric DTC. In addition to ATA initial risk stratification, DRS could further refine risk in pediatric DTCs and help in planning more personalized treatment and follow-up strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsAdenocarcinomaAdultHumansChildAdolescentTreatment OutcomeIodine RadioisotopesRetrospective StudiesThyroidectomyPrognosisRisk AssessmentNeoplasm Recurrence, Local

Stichwörter der Autor:innen

131I treatmentadolescents and young adultschildrendifferentiated thyroid cancerdynamic risk stratificationlong-term outcomes

Substanzen

Iodine Radioisotopes

Autor:innen und Institutionen

  • Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi 110029, India.

ORCID-Profile: Swayamjeet Satapathy, Chandrasekhar Bal

Zitieren

APA

Majeed, A. K., Satapathy, S., Ballal, S., & Bal, C. (2023). Dynamic Risk Stratification for Predicting Long-term Outcomes in Pediatric Differentiated Thyroid Cancers. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgac731

Vancouver

Majeed AK, Satapathy S, Ballal S, Bal C. Dynamic Risk Stratification for Predicting Long-term Outcomes in Pediatric Differentiated Thyroid Cancers. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgac731

BibTeX
@article{Majeed2023,
  author = {Majeed, Althaf K and Satapathy, Swayamjeet and Ballal, Sanjana and Bal, Chandrasekhar},
  title = {Dynamic Risk Stratification for Predicting Long-term Outcomes in Pediatric Differentiated Thyroid Cancers},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2023},
  doi = {10.1210/clinem/dgac731}
}
Kostenlos starten →